Pharma & Biotech News #PharmaBuzz
India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn
Impressions : 1524
Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses
Impressions : 1385
FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development
Impressions : 2119
Aizant's Generics Eltrombopag Olamine Receives Approval in US
28 Apr 2026 //
FDA
Sun Pharma Canada's Generics Doxepin HCl Receives Approval in US
28 Apr 2026 //
FDA
Micro's Generics Ticagrelor Receives Approval in US
27 Apr 2026 //
FDA
Astrazeneca's Biologics Saphnelo Receives Approval in US
24 Apr 2026 //
FDA
Alembic's Generics Fingolimod HCl Receives Approval in US
24 Apr 2026 //
FDA
Navinta's Generics Glycerol Phenylbutyrate Receive Approval in US
23 Apr 2026 //
FDA
Teva' Generics Budesonide & Formoterol Receives Approval in US
23 Apr 2026 //
FDA
ScieGen Pharms' Generics Valsartan Receives Approval in US
23 Apr 2026 //
FDA
Hainan's Generics Tigecycline Receives Tentative Approval in US
23 Apr 2026 //
FDA
Cipla's Generics Albuterol Sulfate Receives Approval in US
22 Apr 2026 //
FDA
Intas' Receives FDA Warning Letter
28 Apr 2026 //
FDA
Lexia's Receives FDA Warning Letter
28 Apr 2026 //
FDA
B. Braun Issues Voluntary Recall of Lactated Ringer's Injection
28 Apr 2026 //
FDA
Enforcement Report - Week of April 22, 2026
22 Apr 2026 //
FDA
Veyx-Pharma B.V. Production Fails EDQM Inspection
21 Apr 2026 //
EMA
Produlab Pharma Production Fails EDQM Inspection
21 Apr 2026 //
EMA
Thrive Health and Wellness' Receives FDA Warning Letter
21 Apr 2026 //
FDA
Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter
21 Apr 2026 //
FDA
Apollo Care's Receives FDA Warning Letter
21 Apr 2026 //
FDA
UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter
21 Apr 2026 //
FDA
Sanofi India Names Rahul Bhatnagar Chairman Of Board
04 May 2026 //
INDPHARMAPOST
Incyte Launches FDA-Approved Jakafi XRTM For Myelofibrosis & More
04 May 2026 //
PRESS RELEASE
Bombay HC Supports GSK In Paxil Trademark Dispute With Shreya
04 May 2026 //
ECONOMICTIMES
UCB To Acquire Candid Therapeutics, Enhancing Immunology
04 May 2026 //
PHARMIWEB
FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data
04 May 2026 //
ENDPOINTS
Weight-loss drugs may also help cut alcohol intake: Study
04 May 2026 //
ECONOMICTIMES
US FDA approves Axsome's drug for Alzheimer's-related agitation
04 May 2026 //
REUTERS
Novartis Reveals North Carolina Factory In $23B US Expansion
04 May 2026 //
ENDPOINTS
Early sales of Lilly's obesity pill appear to trail Novo's
04 May 2026 //
ENDPOINTS
Three Cruise Ship Passengers Die In Suspected Hantavirus Outbreak
03 May 2026 //
REUTERS
GTRI: India Supplies 20% of Global Generics, WTO-Compliant IP
01 May 2026 //
ECONOMICTIMES
Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes
01 May 2026 //
PR NEWSWIRE
Aurobindo Pharma's Curateq Receives Health Canada Approval
01 May 2026 //
ECONOMICTIMES
Apotex First Canadian Pharma Co. To Get Health Canada Approval
01 May 2026 //
PR NEWSWIRE
U.S. Supreme Court Examines Skinny-label Generics Limits
30 Apr 2026 //
ENDPOINTS
Teva Beats Earnings on Branded Drugs as Generics Falter
29 Apr 2026 //
REUTERS
Dr Reddy's Laboratories Receives Approval From Health Canada
29 Apr 2026 //
PRESS RELEASE
Pfizer Secures Deals to Block Heart Drug Generics Until 2030
28 Apr 2026 //
REUTERS
Hikma And Amarin's Generic Drug Case Goes To Supreme Court
28 Apr 2026 //
ENDPOINTS
Novartis Reports Earnings Miss Due To Generic Competition
28 Apr 2026 //
REUTERS
Incyte Launches FDA-Approved Jakafi XRTM For Myelofibrosis & More
04 May 2026 //
PRESS RELEASE
FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data
04 May 2026 //
ENDPOINTS
Weight-loss drugs may also help cut alcohol intake: Study
04 May 2026 //
ECONOMICTIMES
US FDA approves Axsome's drug for Alzheimer's-related agitation
04 May 2026 //
REUTERS
Novartis Reveals North Carolina Factory In $23B US Expansion
04 May 2026 //
ENDPOINTS
Early sales of Lilly's obesity pill appear to trail Novo's
04 May 2026 //
ENDPOINTS
Spinogenix To Showcase Tazbentetol's Neuroprotective Effects
03 May 2026 //
FIRSTWORD PHARMA
Australia Approves First-in-Class cGVHD Therapy
03 May 2026 //
PR NEWSWIRE
Everads Reveals First Human Data On Suprachoroidal Injector
03 May 2026 //
PR NEWSWIRE
Sydnexis To Unveil Phase 3 STAR Trial Data On SYD-101 At ARVO
02 May 2026 //
PHARMIWEB
JP Nadda Highlights India's Focus on APIs and Biologics Research
01 May 2026 //
INDPHARMAPOST
Wanbury Clears Korea FDA Inspection At Patalganga Site
30 Apr 2026 //
INDPHARMAPOST
Solara Completes US FDA Inspection At Puducherry Site
30 Apr 2026 //
INDPHARMAPOST
RPG Life Sciences Expands API Business, Targets GLP-1 Entry
30 Apr 2026 //
ECONOMICTIMES
Formosa Pharma Partners with SERI on Corneal Diseases
30 Apr 2026 //
PR NEWSWIRE
Onco-Innovations Scales Up API Materials for PNKP Program
28 Apr 2026 //
PHARMIWEB
C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)
28 Apr 2026 //
PR NEWSWIRE
Akums Launches Aztreonam-Avibactam to Fight Resistant Infections
28 Apr 2026 //
EXPRESSPHARMA
Chinese API Surge Strains Indian Pharma Amid Mideast Crisis
24 Apr 2026 //
BUSINESS STD
MiKART, Benuvia Partner for Controlled Drug Solutions
23 Apr 2026 //
PR NEWSWIRE
Supreme Court Ask to Intervene in Mail-order Abortion pill fight
03 May 2026 //
FIRSTWORD PHARMA
NAFDAC Warns of Fake Augmentin 625mg in Nigeria
03 May 2026 //
NAFDAC
Several State Still Not File NSQ Data with Central Drug Regulator
02 May 2026 //
PHARMABIZ
InspireMD Initiates Voluntary Recall of CGuard Delivery System
01 May 2026 //
GLOBENEWSWIRE
ORS Sales Melt In March After Govt's Stricter Labelling Norms
01 May 2026 //
ECONOMICTIMES
Patient death prompts FDA pause on Newron's Phase 3 schizophrenia
01 May 2026 //
BIOSPACE
Leanzene Gummies Under Investigation Avoid Fake Complaints & Risk
30 Apr 2026 //
GLOBENEWSWIRE
House Panel Urges Ban on China Data in FDA Approvals
30 Apr 2026 //
ENDPOINTS
FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide
30 Apr 2026 //
FDA
FDA Warns Three Firms For GMP Violations, Cites Incyte
30 Apr 2026 //
RAPS
Three Cruise Ship Passengers Die In Suspected Hantavirus Outbreak
03 May 2026 //
REUTERS
Nomoslogic Founder Launches Lyceum And Odyssey On Dendrite Lite
03 May 2026 //
PHARMIWEB
Mixed Lymphocyte Reaction (MLR) Assay Services
02 May 2026 //
PRESS RELEASE
KFSH, Post-Breakthrough Innovation Is Measured by Repetition
01 May 2026 //
GLOBENEWSWIRE
Smile-Fx Introduces AI Braces System For Predictive Treatment
01 May 2026 //
ACCESSWIRE
SafeSpace Global Launches Tennessee AI Center of Excellence
01 May 2026 //
GLOBENEWSWIRE
Incheon National University Highlights Advanced EV Diagnostics
01 May 2026 //
PR NEWSWIRE
J-Star Partners With Patriot Green for Made-in-USA Battery Deal
01 May 2026 //
GLOBENEWSWIRE
India Transforms qPCR via Scale, Structural Shifts
01 May 2026 //
INDPHARMAPOST
Breaking the Silence: Bladder Cancer Awareness Month Begins
01 May 2026 //
GLOBENEWSWIRE
Biomarin Reveals VOXZOGO Impact On Achondroplasia In Children
03 May 2026 //
PR NEWSWIRE
Novartis Gets Health Canada Nod For Fabhalta In Adult C3G
02 May 2026 //
FIRSTWORD PHARMA
EU Approves IMCIVREE for Acquired Hypothalamic Obesity
01 May 2026 //
FIRSTWORD PHARMA
Arrowhead Gets TGA Approval for Plozasiran in FCS in Australia
01 May 2026 //
FIRSTWORD PHARMA
SPARC To Sell Rare Pediatric Disease Priority Review Voucher
01 May 2026 //
EXPRESSPHARMA
LEO Pharma Strengthens Rare Skin Disease Focus With Replay Gene
30 Apr 2026 //
PHARMIWEB
Larimar backs skin biomarker in Friedreich's ataxia
30 Apr 2026 //
FIRSTWORD PHARMA
AstraZeneca Cuts Asthma and Rare Disease Units; Boosts Cancer
30 Apr 2026 //
BIOSPACE
Chiesi Snaps Up Kalvista For $1.9B, Betting Big On Rare Disease
30 Apr 2026 //
BIOSPACE
Expression Therapeutics Secures Rare FDA Approval for Hemophilia
29 Apr 2026 //
PR NEWSWIRE
Sanofi India Names Rahul Bhatnagar Chairman Of Board
04 May 2026 //
INDPHARMAPOST
Bombay HC Supports GSK In Paxil Trademark Dispute With Shreya
04 May 2026 //
ECONOMICTIMES
UCB To Acquire Candid Therapeutics, Enhancing Immunology
04 May 2026 //
PHARMIWEB
Ozempic Maker To Pilot Diabetes, Obesity Treatments In Singapore
03 May 2026 //
FIRSTWORD PHARMA
Two separate venues for pharma industry expos in Delhi-NCR
03 May 2026 //
ECONOMICTIMES
Avicanna Announces Change In Board Of Directors
03 May 2026 //
FIRSTWORD PHARMA
Visiocore's Vision Support Evaluated: Amazonian Morning Flush
02 May 2026 //
GLOBENEWSWIRE
Indian Lifesciences Sector Faces Critical Cybersecurity Risks
02 May 2026 //
PHARMABIZ
Bristol Myers Sees Pivotal Year, AI Expansion Questioned
02 May 2026 //
ENDPOINTS
Virupaksha Organics IPO GMP, Price, Allotment, Profit 2026
01 May 2026 //
IPOCENTRAL

